RE: No Dx Strategy????28 Mar 2023 15:26
The first, Affimer, has been developed as an alternative to the $100 billion antibody therapy market, and is proposed to eliminate the many negatives of using antibodies to combat disease, including the reliance on the response of an animal’s immune system, their poor specificity with unintended side effects, and the high cost of manufacture.